Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Ophthalmology|December 3, 2014
Predictive value of heidelberg retina tomograph parameters for the development of glaucoma in the European glaucoma prevention studyStefano Miglior, Thierry Zeyen, Esther M Hoffmann, et al.
Cancers|May 4, 2026
Comparing Response Evaluation Methods for PRRT in Neuroendocrine Tumors: Insights from an Exploratory StudyPriscilla Guglielmo, Carlo Carnaghi, Alexia Francesca Bertuzzi, et al.
The British Journal of Ophthalmology|November 17, 2019
Exploring the gap between diagnostic research outputs and clinical use of OCT for diagnosing glaucomaManuele Michelessi, Luciano Quaranta, Ivano Riva, et al.
Acta Ophthalmologica|October 20, 2018
Macular versus nerve fibre layer versus optic nerve head imaging for diagnosing glaucoma at different stages of the disease: Multicenter Italian Glaucoma Imaging StudyManuele Michelessi, Ivano Riva, Enrico Martini, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensusJohn Thygesen, Reinhard Burk, Roberto Carassa, et al.
Ophthalmology|November 11, 2006
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension, , Mae O Gordon, et al.
Cancers|March 28, 2025
Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study)Maria Susanna Grimaudo, Federico D'Orazio, Salvatore Lorenzo Renne, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mmRoberta Elisa Rossi, Maria Terrin, Silvia Carrara, et al.
Drug Design, Development and Therapy|November 26, 2015
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcomaRita De Sanctis, Andrea Marrari, Silvia Marchetti, et al.
Frontiers in Endocrinology|September 17, 2025
Management of type I gastric-neuroendocrine tumors: the less the better?Roberta Elisa Rossi, Benedetta Masoni, Valeria Poletti, et al.
Pageof 7